burkholderia pseudomallei | brucella neotomae | GeneSet Name |
0.16712 | 0.00269 | NETPATH_IL_4_PATHWAY_DOWN |
0.00000 | 0.07337 | NCI_AURORA_B_PATHWAY |
0.00015 | 0.18522 | GERY_CEBP_TARGETS |
0.13793 | 0.10715 | SA_MMP_CYTOKINE_CONNECTION |
0.00741 | 0.13128 | NCI_ERBB_NETWORK_PATHWAY |
0.00000 | 0.00862 | GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP |
0.00002 | 0.03682 | GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP |
0.00000 | 0.14815 | SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN |
0.00000 | 0.19269 | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN |
0.01913 | 0.16767 | MAHAJAN_RESPONSE_TO_IL1A_UP |
0.00000 | 0.17236 | LEE_EARLY_T_LYMPHOCYTE_UP |
0.00000 | 0.15769 | HORIUCHI_WTAP_TARGETS_DN |
0.00000 | 0.00137 | CHANG_CORE_SERUM_RESPONSE_UP |
0.08011 | 0.13116 | NEWMAN_ERCC6_TARGETS_DN |
0.00000 | 0.00560 | OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP |
0.05958 | 0.11314 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS |
0.00000 | 0.17842 | MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN |
0.00000 | 0.00378 | NCI_VIRAL_MESSENGER_RNA_SYNTHESIS |
0.00750 | 0.00010 | LINDSTEDT_DENDRITIC_CELL_MATURATION_A |
0.02727 | 0.04424 | ELVIDGE_HYPOXIA_UP |
0.06915 | 0.03884 | XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP |
0.00290 | 0.01260 | AMIT_EGF_RESPONSE_40_HELA |
0.16021 | 0.01290 | NETPATH_IL_7_PATHWAY_UP |
0.12979 | 0.01038 | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP |
0.00000 | 0.06164 | KOBAYASHI_EGFR_SIGNALING_24HR_DN |
0.06173 | 0.01910 | CORUM_PA700_COMPLEX |
0.16014 | 0.16364 | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP |
0.00000 | 0.00636 | PUJANA_CHEK2_PCC_NETWORK |
0.00143 | 0.09086 | HINATA_NFKB_TARGETS_KERATINOCYTE_UP |
0.00000 | 0.00237 | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP |
0.14963 | 0.11822 | DORN_ADENOVIRUS_INFECTION_48HR_DN |
0.00292 | 0.11766 | AMIT_SERUM_RESPONSE_60_MCF10A |
0.07914 | 0.00644 | DUTTA_APOPTOSIS_VIA_NFKB |
0.00738 | 0.09248 | DORSEY_GAB2_TARGETS |
0.04849 | 0.00214 | DIRMEIER_LMP1_RESPONSE_EARLY |
0.19046 | 0.08266 | WOTTON_RUNX_TARGETS_UP |
0.00000 | 0.00935 | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA |
0.10469 | 0.00575 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES |
0.00909 | 0.01309 | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP |
0.05647 | 0.01819 | ONDER_CDH1_TARGETS_3_DN |
0.00000 | 0.01477 | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP |
0.00027 | 0.02726 | AMIT_EGF_RESPONSE_120_HELA |
0.00000 | 0.09810 | MORI_IMMATURE_B_LYMPHOCYTE_DN |
0.00000 | 0.06044 | DANG_MYC_TARGETS_UP |
0.08082 | 0.11809 | TAVOR_CEBPA_TARGETS_UP |
0.00209 | 0.03432 | SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER |
0.00000 | 0.08362 | BLUM_RESPONSE_TO_SALIRASIB_DN |
0.00000 | 0.02657 | RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN |
0.12228 | 0.18134 | NAGASHIMA_NRG1_SIGNALING_DN |
0.02599 | 0.11404 | AMIT_SERUM_RESPONSE_120_MCF10A |
0.00000 | 0.04591 | SESTO_RESPONSE_TO_UV_C3 |
0.13600 | 0.03242 | VERHAAK_AML_WITH_NPM1_MUTATED_UP |
0.05129 | 0.05694 | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN |
0.11502 | 0.01183 | GEISS_RESPONSE_TO_DSRNA_UP |
0.00000 | 0.00145 | NCI_MRNA_SPLICING___MAJOR_PATHWAY |
0.00009 | 0.16491 | GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN |
0.00000 | 0.13378 | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 |
0.00000 | 0.05928 | ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP |
0.00000 | 0.07216 | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP |
0.00000 | 0.02738 | ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER |
0.00000 | 0.05899 | TIAN_TNF_SIGNALING_VIA_NFKB |
0.09754 | 0.07619 | HUMMEL_BURKITTS_LYMPHOMA_DN |
0.00000 | 0.01336 | NAGASHIMA_EGF_SIGNALING_UP |
0.00000 | 0.16069 | MISSIAGLIA_REGULATED_BY_METHYLATION_DN |
0.00000 | 0.00562 | NCI_MRNA_SPLICING___MINOR_PATHWAY |
0.00375 | 0.02489 | AMIT_EGF_RESPONSE_60_MCF10A |
0.00000 | 0.04383 | BENPORATH_PROLIFERATION |
0.02392 | 0.17773 | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION |
0.01125 | 0.12949 | CHEN_HOXA5_TARGETS_6HR_UP |
0.01050 | 0.00128 | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP |
0.00000 | 0.11385 | WHITEFORD_PEDIATRIC_CANCER_MARKERS |
0.00000 | 0.08875 | RHODES_UNDIFFERENTIATED_CANCER |
0.19387 | 0.17788 | BIOCARTA_EPONFKB_PATHWAY |
0.03967 | 0.08144 | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN |
0.00000 | 0.00389 | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN |
0.19819 | 0.06343 | DORN_ADENOVIRUS_INFECTION_32HR_DN |
0.00000 | 0.15111 | ZHAN_MULTIPLE_MYELOMA_PR_UP |
0.02367 | 0.00132 | CROONQUIST_STROMAL_STIMULATION_UP |
0.15269 | 0.18216 | SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP |
0.00000 | 0.00153 | REACTOME_MRNA_SPLICING |
0.11122 | 0.07569 | HALMOS_CEBPA_TARGETS_UP |
0.00000 | 0.01124 | MARKEY_RB1_ACUTE_LOF_DN |
0.07469 | 0.07172 | REACTOME_PHASE_1_FUNCTIONALIZATION_OF_COMPOUNDS |
0.00000 | 0.12768 | KAUFFMANN_MELANOMA_RELAPSE_UP |
0.00025 | 0.00665 | MAHADEVAN_RESPONSE_TO_MP470_DN |
0.16949 | 0.17495 | HARRIS_HYPOXIA |
0.14993 | 0.06990 | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP |
0.00000 | 0.03264 | CAIRO_HEPATOBLASTOMA_CLASSES_UP |
0.00280 | 0.11317 | TIAN_TNF_SIGNALING_NOT_VIA_NFKB |
0.00002 | 0.06679 | NAGASHIMA_NRG1_SIGNALING_UP |
0.03675 | 0.01093 | SOUCEK_MYC_TARGETS |
0.00000 | 0.13113 | SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM |
0.18858 | 0.14321 | BIOCARTA_PPARA_PATHWAY |
0.05436 | 0.01515 | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN |
0.14983 | 0.09849 | MAHADEVAN_RESPONSE_TO_MP470_UP |
0.05896 | 0.02413 | FERRARI_RESPONSE_TO_FENRETINIDE_UP |
0.00256 | 0.00155 | DAUER_STAT3_TARGETS_UP |
0.02735 | 0.04575 | ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN |
0.00000 | 0.16167 | FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN |
0.00659 | 0.06879 | MENSE_HYPOXIA_UP |
0.17112 | 0.09764 | ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN |
0.02574 | 0.04600 | AMIT_EGF_RESPONSE_60_HELA |
0.00000 | 0.00770 | WINNEPENNINCKX_MELANOMA_METASTASIS_UP |
0.02586 | 0.00657 | DAZARD_UV_RESPONSE_CLUSTER_G2 |
0.03571 | 0.02011 | CHEN_HOXA5_TARGETS_9HR_UP |
0.00000 | 0.04605 | SCHUHMACHER_MYC_TARGETS_UP |
0.06818 | 0.03264 | AMIT_SERUM_RESPONSE_40_MCF10A |
0.01261 | 0.00041 | SEKI_INFLAMMATORY_RESPONSE_LPS_UP |
0.00000 | 0.11638 | MANALO_HYPOXIA_DN |
0.00000 | 0.07552 | GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP |
0.00139 | 0.00387 | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP |
0.02223 | 0.00980 | BROWNE_HCMV_INFECTION_4HR_UP |
0.00000 | 0.00856 | REACTOME_MRNA_SPLICING_MINOR_PATHWAY |
0.00000 | 0.10679 | BIDUS_METASTASIS_UP |
0.00000 | 0.00059 | HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP |
0.00000 | 0.00365 | YU_MYC_TARGETS_UP |
0.05021 | 0.10627 | KIM_WT1_TARGETS_UP |
0.02548 | 0.01050 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE |
0.00000 | 0.05710 | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP |
0.00000 | 0.03267 | CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN |
0.00019 | 0.00256 | UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN |
0.00000 | 0.07247 | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP |
0.00000 | 0.10986 | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN |
0.00000 | 0.12453 | CAFFAREL_RESPONSE_TO_THC_24HR_5_DN |
0.08705 | 0.15914 | HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN |
0.00000 | 0.08251 | CHANG_CYCLING_GENES |
0.03396 | 0.11243 | ELVIDGE_HYPOXIA_BY_DMOG_UP |
0.03694 | 0.12777 | DASU_IL6_SIGNALING_UP |
0.00000 | 0.00159 | WONG_EMBRYONIC_STEM_CELL_CORE |
0.00000 | 0.06329 | RHODES_CANCER_META_SIGNATURE |
0.00000 | 0.11344 | FARMER_BREAST_CANCER_CLUSTER_2 |
0.00000 | 0.00010 | GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP |
0.02880 | 0.00123 | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN |
0.03179 | 0.17310 | RICKMAN_HEAD_AND_NECK_CANCER_E |
0.19540 | 0.08584 | WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN |
0.01688 | 0.10655 | PRAMOONJAGO_SOX4_TARGETS_UP |
0.09787 | 0.16797 | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN |
0.00345 | 0.15073 | KIM_WT1_TARGETS_8HR_UP |
0.00094 | 0.15801 | GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN |